James Jones Net Worth

The estimated Net Worth of James Jones is at least $35.5 Thousand dollars as of 1 December 2022. Mr. Jones owns over 667 units of Cumberland Pharmaceuticals stock worth over $35,498 and over the last 14 years he sold CPIX stock worth over $0. In addition, he makes $0 as Independent Director at Cumberland Pharmaceuticals.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Jones CPIX stock SEC Form 4 insiders trading

James has made over 15 trades of the Cumberland Pharmaceuticals stock since 2010, according to the Form 4 filled with the SEC. Most recently he bought 667 units of CPIX stock worth $1,487 on 1 December 2022.

The largest trade he's ever made was buying 3,000 units of Cumberland Pharmaceuticals stock on 28 May 2010 worth over $20,700. On average, James trades about 359 units every 120 days since 2010. As of 1 December 2022 he still owns at least 26,293 units of Cumberland Pharmaceuticals stock.

You can see the complete history of Mr. Jones stock trades at the bottom of the page.

James Jones biography

James R. Jones serves as Independent Director of the Company. Mr. Jones’ 36 year career in professional accounting at KPMG LLP included the role of Managing Partner at their Nashville, Tennessee office from 1999 to 2006. He served in various capacities during his career at KPMG which also included positions at their offices in Jackson, Mississippi, Washington, D.C. and Greenville, South Carolina. During his tenure with KPMG, Mr. Jones led a team of more than 100 individuals providing accounting services for an extensive client base. Following retirement in 2006, he has served as an advisor as well as provided various consulting services to several companies, including acting as liaison between management and the board of directors of a long-term care facility and serving as interim CEO of a charitable organization. He is currently a board director and member of the audit committees of Argent Trust Company of Tennessee and Belmont University. Mr. Jones also serves as a member of our Audit Committee and is our Audit Committee financial expert. Mr. Jones holds a B.S. from Mississippi College and an M.B.A from Mississippi State University. The Board of Directors believes Mr. Jones’ significant accounting background will strengthen Cumberland’s existing financial capabilities and play a key role as the company is subject to increasingly stringent accounting and auditing regulations as a public entity.

How old is James Jones?

James Jones is 72, he's been the Independent Director of Cumberland Pharmaceuticals since 2010. There are 3 older and 16 younger executives at Cumberland Pharmaceuticals. The oldest executive at Cumberland Pharmaceuticals Inc. is Jonathan Griggs, 85, who is the Independent Director.

What's James Jones's mailing address?

James's mailing address filed with the SEC is 1600 WEST END AVENUE, SUITE 1300, , NASHVILLE, TN, 37203.

Insiders trading at Cumberland Pharmaceuticals

Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv, and Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.

What does Cumberland Pharmaceuticals do?

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.

Complete history of Mr. Jones stock trades at Cumberland Pharmaceuticals

Cumberland Pharmaceuticals executives and stock owners

Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:

• A. Kazimi,
  Chairman of the Board, Chief Executive Officer
• A. J. Kazimi,
  Founder, Chairman, Pres & CEO
• Leo Pavliv,
  Executive Vice President - Operations, Chief Development Officer
• Leo B. Pavliv,
  Exec. VP of Operations & Chief Devel. Officer
• Martin Cearnal,
  Executive Vice President, Chief Commercial Officer, Director
• Martin E. Cearnal,
  Exec. VP, Chief Commercial Officer & Director
• James Herman,
  Vice President - National Accounts, Chief Compliance Officer
• James Lowrance Herman,
  Sr. VP of National Accounts & Chief Compliance Officer
• Michael Bonner,
  Senior Director Finance and Accounting and Chief Financial Officer
• Caroline Young,
  Independent Director
• Kenneth Krogulski,
  Independent Director
• James Jones,
  Independent Director
• Joey Jacobs,
  Independent Director
• Jonathan Griggs,
  Independent Director
• Joseph Galante,
  Independent Director
• Gordon Bernard,
  Independent Director
• Erin Smith Gull,
  Sr. Corp. Relations Associate
• Adam S. Mostafa,
  Managing Director
• Cindy B. Patton,
  Sr. Director of Field Marketing
• Jean W. Marstiller,
  Sr. VP of Admin. Services & Corp. Sec.
• John Michael Hamm,
  Director of Fin. & Accounting and CFO
• Thomas R Lawrence,
  Director
• Martin S Jr Brown,
  
• Chris T. Bitterman,
  Vice Pres Sales & Marketing
• Rick Scott Greene,
  Chief Financial Officer
• Robert Edwards,
  Director
• Jean W Marstiller,
  Sr. VP & Corp. Secretary
• Lawrence W Greer,
  Director
• David L Lowrance,
  Vice President and CFO
• Todd M. Anthony,
  Vice Pres Organizational Dev
• John M. Hamm,
  VP Chief Financial Officer